Essential CNS Drug Development
eBook - PDF

Essential CNS Drug Development

  1. English
  2. PDF
  3. Available on iOS & Android
eBook - PDF

Essential CNS Drug Development

About this book

Central Nervous System disorders have an enormous impact on individuals and on society as a whole. The development of better treatments is crucial and is a major focus of pharmaceutical and biotechnology companies. This book explains the complicated process of CNS drug development in a way that is engaging for any interested professional or student. Chapters cover each stage of drug development, from pre-clinical research through all phases of clinical trials, to reporting to the regulatory authorities. Other key issues covered include strategic considerations, regulatory constraints, dissemination of results and ethical considerations. The user-friendly format and style enable readers to find important information quickly and easily. Written and edited by experts from different sectors actively engaged in CNS drug development, this is a unique resource for drug developers, investigators, academics and clinicians.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Essential CNS Drug Development by Amir Kalali,Sheldon Preskorn,Joseph Kwentus,Stephen M. Stahl in PDF and/or ePUB format, as well as other popular books in Medicine & Psychiatry & Mental Health. We have over one million books available in our catalogue for you to explore.

Table of contents

  1. Essential CNS Drug Development
  2. Title
  3. Copyright
  4. Contents
  5. Contributors
  6. Preface
  7. Chapter 1 History of CNS drug development
  8. Chapter 2 Regulatory issues
  9. Chapter 3 Essential CNS drug development – pre-clinical development
  10. Chapter 4 Phase I trials: from traditional to newer approaches
  11. Chapter 5 Phase II development and the path to personalized medicine in CNS disease
  12. Chapter 6 CNS drug development – Phase III
  13. Chapter 7 Statistics issues relevant to CNS drug development
  14. Chapter 8 Clinical trials management at company level
  15. Chapter 9 Clinical trials management at the site level
  16. Chapter 10 Medical writing for CNS indications
  17. Chapter 11 Dissemination of clinical trial information: multiple audiences, multiple formats
  18. Chapter 12 The importance of treating cognition in schizophrenia and other severe mental illnesses: background, strategies, and findings to date
  19. Chapter 13 Leveraging disruptive technologies to drive innovation in CNS clinical drug development
  20. Index